Meeting 1: Clinical Utility of Treating Patients with Compounded "Bioidentical Hormone Replacement Therapy”
The National Academies of Sciences, Engineering, and Medicine is pleased to announce the first open session meeting for the Committee on Clinical Utility of Treating Patients with Compounded "Bioidentical Hormone Replacement Therapy”. The public meeting will be held on March 5th, 2019 in the Keck Center Building in Room 101 (500 5th Street NW, Washington DC, 20001) from 1:00pm to 5:00pm (ET).
This meeting will provide an opportunity for the committee to discuss their Statement of Task with representatives from the U.S. Food and Drug Administration (the study sponsors) and gather data and context information from relevant subject matter experts. There will also be a short Q&A session with the viewing public.